MOUNTAIN VIEW, Calif., March 21, 2022 Iridex Corporation , a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced. | March 21, 2022
atulpmrApril 25, 2021 1
The Drug Eluting Beads Market report by Persistence Market Research is focusing on the fact that healthcare providers are into collection of socioeconomic information of the patients, so that tracking at any point of time is possible. This on-the-go monitoring is amongst the ongoing trends in the healthcare industry.
Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chem
Share this article
Share this article
DENVER, April 20, 2021 /PRNewswire/ CereHealth Corp., a data analytics technology company that provides Medical Analytics as a Service, announced today the addition of James Chomas, Ph.D. as the company s Chief Executive Officer. Dr. Chomas will work closely with John Kelley, who has served as CereHealth s CEO since 2009 and driven the company s evolution from a single site brain imaging clinic to a nationwide neurodiagnostic network and leader in advanced CNS data analytics and technologies. Mr. Kelley will transition to the role of Executive Director and continue serving as Chair of the Board. He will continue to have direct involvement in the company s strategies to bring its browser-based, cloud-enabled imaging and data analytics platforms, CereMetrixAi™ and iLLUMEAi, to a global market.
CereHealth Welcomes New Members to its Scientific and Medical Advisory Board
James Chomas and Ty Vachon add expertise in medical device technology and machine learning in medical imaging and healthcare
News provided by
Share this article
Share this article
DENVER, Dec. 16, 2020 /PRNewswire/ CereHealth Corp., a data analytics technology company that provides Medical Analytics as a Service announced today the addition of James Chomas, Ph.D. and Ty Vachon, M.D. to their Scientific and Medical Advisory Board. They join retired Major General Gale Pollock in pursuit of the company s strategic focus to bring its browser-based, cloud-enabled imaging and data analytics platforms with a combination of proprietary and integrated software solutions to a global market.